NCT02608489View on ClinicalTrials.gov

Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Dry Eye Syndromes
Interventions
DRUG

Diquafosol (Diquas)

Diquafosol group used diquafosol 6 times a day during study period.

DRUG

Sodium Hyaluronate (Hyalein)

Hyaluronate group used sodium hyaluronate 6 times a day during study period.

All Listed Sponsors
lead

Soonchunhyang University Hospital

OTHER

NCT02608489 - Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery | Biotech Hunter | Biotech Hunter